Serina Therapeutics SER
NYSE SER
$2.00 -0.01 (-0.48%)
As of: Oct 1, 2026 · 3:14 PM EDT

Serina Therapeutics (SER) Preferred Stock Liabilities (2022 - 2023)

Updated

Serina Therapeutics' Preferred Stock Liabilities was $36.4 million in Q4 2023, compared with $200,000 a year earlier and up 1.2% from the prior quarter.

Analysis

Serina Therapeutics (SER) Preferred Stock Liabilities (2022 - 2023) Analysis & Trends

  • In earlier years, Preferred Stock Liabilities was $200,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Serina Therapeutics 32.93 Mn -7.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 36.40 Mn
Sep 30, 2023 35.96 Mn
Dec 31, 2022 200,000.00
API Access

Serina Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=SER&period=max&api_key=YOUR_API_KEY